Peptides

Commercially Available:

  • Octreotide (Somatostation, Growth Hormone Inibitor)
  • Bivalirudin (Anti-thrombotic agent)
  • Eptifibatide (Anti-thrombotic agent)

Peptides

Commercially available:

  • Octreotide (Somatostatin, Growth hormone inibitor)
  • Bivalirudin (Anti-thrombotic agent)
  • Eptifibatide (Anti-thrombotic agent)

Under development:

  • Pramlintide (Amylin analog, Type II diabetes)
  • Exenatide (GLP-1 analog, Type II diabetes)
  • Desmopressin (Diabetes incipidus)

Finished Products dossiers of these peptides are also under development.

For more information about our existing portfolio and our pipeline products please e-mail us.

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.






© 2016 USV Private Limited. All Rights Reserved.